BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25548617)

  • 1. Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.
    Pastromas S; Manolis AS
    World J Cardiol; 2014 Dec; 6(12):1270-7. PubMed ID: 25548617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site of latest activation in patients eligible for cardiac resynchronization therapy: patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology.
    van Bommel RJ; Ypenburg C; Mollema SA; Borleffs CJ; Delgado V; Bertini M; Marsan NA; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2011 Jun; 161(6):1060-6. PubMed ID: 21641351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
    Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous His Bundle and Left Ventricular Pacing for Optimal Cardiac Resynchronization Therapy Delivery: Acute Hemodynamic Assessment by Pressure-Volume Loops.
    Padeletti L; Pieragnoli P; Ricciardi G; Innocenti L; Checchi L; Padeletti M; Michelucci A; Picariello F; Valsecchi S
    Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy.
    Vanderheyden M; De Backer T; Rivero-Ayerza M; Geelen P; Bartunek J; Verstreken S; De Zutter M; Goethals M
    Heart Rhythm; 2005 Oct; 2(10):1066-72. PubMed ID: 16188583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute biventricular hemodynamic effects of cardiac resynchronization therapy in right bundle branch block.
    Houston BA; Sturdivant JL; Yu Y; Gold MR
    Heart Rhythm; 2018 Oct; 15(10):1525-1532. PubMed ID: 29800750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different regions of latest electrical activation during left bundle-branch block and right ventricular pacing in cardiac resynchronization therapy patients determined by coronary venous electro-anatomic mapping.
    Mafi Rad M; Blaauw Y; Dinh T; Pison L; Crijns HJ; Prinzen FW; Vernooy K
    Eur J Heart Fail; 2014 Nov; 16(11):1214-22. PubMed ID: 25315161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Response to Cardiac Resynchronization Therapy.
    Allison JD; Biton Y; Mela T
    J Innov Card Rhythm Manag; 2022 May; 13(5):4994-5003. PubMed ID: 35655810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing CRT - Do We Need More Leads and Delivery Methods.
    Martens P; Verbrugge FH; Mullens W
    J Atr Fibrillation; 2015; 7(6):1202. PubMed ID: 27957161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular lead placement in cardiac resynchronization therapy: where and how?
    Khan FZ; Virdee MS; Fynn SP; Dutka DP
    Europace; 2009 May; 11(5):554-61. PubMed ID: 19372115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in congestive heart failure: Ready for prime time?
    Manolis AS
    Heart Rhythm; 2004 Sep; 1(3):355-63. PubMed ID: 15851184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison.
    Lustgarten DL; Crespo EM; Arkhipova-Jenkins I; Lobel R; Winget J; Koehler J; Liberman E; Sheldon T
    Heart Rhythm; 2015 Jul; 12(7):1548-57. PubMed ID: 25828601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in coronary microvascular resistance through cardiac resynchronization and its impact on chronic reverse remodelling of left ventricle in patients with non-ischaemic cardiomyopathy.
    Itoh M; Shinke T; Yoshida A; Kozuki A; Takei A; Fukuzawa K; Kiuchi K; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Otake H; Nagoshi R; Shite J; Hirata K
    Europace; 2015 Sep; 17(9):1407-14. PubMed ID: 25662988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.
    Badran HA; Kamel JZ; Mohamed TR; Abdelhamid MA
    J Interv Card Electrophysiol; 2017 Apr; 48(3):299-306. PubMed ID: 28194611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.